default image

Urologie

With emergency ambulance

Information and services of the department

  • Number of inpatient cases: 23

Services search (in the department)


Illness Number of cases
Malignant neoplasm of bladder - Malignant neoplasm of overlapping sites of bladder (C67.8) 4
Carcinoma in situ of other and unspecified sites - Carcinoma in situ of bladder (D09.0) 4
Malignant neoplasm of testis (C62.1) not specified
Malignant neoplasm of bladder - Malignant neoplasm of trigone of bladder (C67.0) not specified
Malignant neoplasm of bladder - Malignant neoplasm of dome of bladder (C67.1) not specified
Malignant neoplasm of bladder - Malignant neoplasm of lateral wall of bladder (C67.2) not specified
Malignant neoplasm of bladder - Malignant neoplasm of posterior wall of bladder (C67.4) not specified
Malignant neoplasm of bladder - Malignant neoplasm of bladder neck (C67.5) not specified
Neoplasm of uncertain or unknown behaviour of urinary organs - Neoplasm of uncertain behavior of bladder (D41.4) not specified
Obstructive and reflux uropathy - Hydroureter (N13.4) not specified
Treatment Number
Surgical incision, removal or destruction of diseased tissue in the urinary bladder, with access through the urethra (5-573.40) 16
Injection or administration of medicines into the urinary bladder (8-132.2) 4
Computed tomography of the chest with contrast medium (3-222) 0
Computed tomography of the abdomen with contrast medium (3-225) 0
Computer-assisted analysis of the images with 3D-analysis (3-990) 0
(5-573.32) 0
Surgical dilatation of the urethral opening (5-581.0) 0
Surgical incision into diseased tissue in the urethra, with access through the urethra (5-585.1) 0
Surgical incision into the scrotum or the coat of the testicle (5-610.0) 0
Surgical incision into the scrotum or the coat of the testicle (5-610.1) 0

Hospital information and services for all specialist departments

External comparative quality assurance
Further information
  • External quality assurance according to state law
    No participation
  • Quality of participation in the Disease Management Programme (DMP)
    No participation
  • Implementation of resolutions of the Federal Joint Committee on quality assurance (G-BA)
    No participation
Number Group
65 Medical specialists (m/f) , psychological psychotherapists (m/f) and child and adolescent psychotherapists (m/f) who are subject to the obligation to undergo further training*
9 Number of medical specialists (m/f) from no. 1 who have completed a five-year period of further training and are therefore subject to the obligation to provide evidence
8 Number of those persons from no. 2 who have provided proof of further training according to Article 3 of the G-BA regulations
* according to the “Provisions of the Joint Federal Committee for the Further Training of Medical Specialists (m/f), Psychological Psychotherapists (m/f) and Child and Adolescent Psychotherapists (m/f) in Hospitals”
Job Explanation
Student training (clinical traineeship / internship year)
Project-related cooperation with colleges and universities
No. Training in other healing professions Comment
HB03 Physical therapist / physiotherapist (m/f)
HB01 Nurse and health care worker (m/f)
HB07 Surgical technical assistant (m/f)
HB15 Anaesthesia technical assistant (m/f)
HB10 Midwife (m/f)
HB17 Auxiliary nurse (m/f)
HB19 Nursing professionals

Erika Pankratz

Mitarbeiterin Qualitätsmanagement

Phone: 04841 -660-1358
Mail: ed.fn-mukinilk@edrewhcseb

Simon Wenzel

Leitung Qualitätsmanagement

Phone: 04841 -660-1847
Mail: ed.fn-mukinilk@leznew.nomis

Kirsten Dahms

Ärztliche Leitung Krankenhaushygiene und Infektionsprävention

Phone: 04841 -660-1744
Mail: ed.fn-mukinilk@smhad.netsrik